Context Therapeutics Inc. (CNTX) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q1 EPS of ($0.40), $0.06 worse than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Goldman Sachs Upgrades Drax Group Plc. (DRX:LN) (DRXGY) to Buy
- Reliance Industries (RELIANCE:IN) PT Raised to INR1,710 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
